中外医疗
中外醫療
중외의료
China Foreign Medical Treatment
2015年
28期
156-157
,共2页
依托考昔%塞来昔布%急性痛风
依託攷昔%塞來昔佈%急性痛風
의탁고석%새래석포%급성통풍
Etoricoxib%Celecoxib%Acute gout
目的 探讨依托考昔与塞来昔布治疗急性痛风的疗效与安全性. 方法 随机选取该院2013年4月—2014年6月收治的80例急性通风患者,并将其随机分为实验组与对照组,各40例. 其中实验组患者采用依托考昔进行口服治疗;对照组患者采用塞来昔布进行口服治疗. 对比两组通风患者的各项数据. 结果 两组急性痛风患者进行治疗后发现,实验组患者的其他各项指标均优于对照组患者.两组急性痛风患者治疗后的VAS评分存在明显差异,P<0.05,差异有统计学意义.结论依托考昔能够有效的对急性痛风患者进行治疗,具有安全性高、起效快等优点,值得临床推广使用.
目的 探討依託攷昔與塞來昔佈治療急性痛風的療效與安全性. 方法 隨機選取該院2013年4月—2014年6月收治的80例急性通風患者,併將其隨機分為實驗組與對照組,各40例. 其中實驗組患者採用依託攷昔進行口服治療;對照組患者採用塞來昔佈進行口服治療. 對比兩組通風患者的各項數據. 結果 兩組急性痛風患者進行治療後髮現,實驗組患者的其他各項指標均優于對照組患者.兩組急性痛風患者治療後的VAS評分存在明顯差異,P<0.05,差異有統計學意義.結論依託攷昔能夠有效的對急性痛風患者進行治療,具有安全性高、起效快等優點,值得臨床推廣使用.
목적 탐토의탁고석여새래석포치료급성통풍적료효여안전성. 방법 수궤선취해원2013년4월—2014년6월수치적80례급성통풍환자,병장기수궤분위실험조여대조조,각40례. 기중실험조환자채용의탁고석진행구복치료;대조조환자채용새래석포진행구복치료. 대비량조통풍환자적각항수거. 결과 량조급성통풍환자진행치료후발현,실험조환자적기타각항지표균우우대조조환자.량조급성통풍환자치료후적VAS평분존재명현차이,P<0.05,차이유통계학의의.결론의탁고석능구유효적대급성통풍환자진행치료,구유안전성고、기효쾌등우점,치득림상추엄사용.
Objective To investigate the efficacy and safety of etoricoxib and celecoxib in the treatment of acute gout. Methods 80 cases of acute ventilation were selected from April 2013 to June 2014, and were randomly divided into experimental group and control group, 40 cases in each group. In the experimental group were treated with etoricoxib oral treatment;the control group were treated with celecoxib oral treatment. Compare the data of two groups of ventilation patients. Results Two groups of patients with acute gout were treated, the other indicators of the experimental group were better than those of the control group. There were sig-nificant differences in VAS score between the two groups after treatment, P<0.05, the difference was statistically significant. Con-clusion Relying on past exam can effectively in patients with acute gout treatment, which has the advantages of high safety, fast action and so on, worthy of clinical use.
